Exelixis
EXEL
#1727
Rank
NZ$20.57 B
Marketcap
NZ$76.75
Share price
-0.36%
Change (1 day)
18.67%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company